↓ Skip to main content

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by…

Overview of attention for article published in BMC Cancer, June 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
229 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study
Published in
BMC Cancer, June 2017
DOI 10.1186/s12885-017-3420-4
Pubmed ID
Authors

Quentin Jacquinot, Nathalie Meneveau, Marion Chatot, Franck Bonnetain, Bruno Degano, Malika Bouhaddi, Gilles Dumoulin, Dewi Vernerey, Xavier Pivot, Fabienne Mougin

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 229 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 229 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 36 16%
Student > Bachelor 32 14%
Student > Ph. D. Student 19 8%
Student > Postgraduate 18 8%
Other 14 6%
Other 35 15%
Unknown 75 33%
Readers by discipline Count As %
Medicine and Dentistry 47 21%
Nursing and Health Professions 37 16%
Sports and Recreations 31 14%
Pharmacology, Toxicology and Pharmaceutical Science 5 2%
Agricultural and Biological Sciences 4 2%
Other 20 9%
Unknown 85 37%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2018.
All research outputs
#8,310,091
of 13,793,900 outputs
Outputs from BMC Cancer
#2,247
of 5,193 outputs
Outputs of similar age
#149,993
of 266,309 outputs
Outputs of similar age from BMC Cancer
#1
of 2 outputs
Altmetric has tracked 13,793,900 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,193 research outputs from this source. They receive a mean Attention Score of 4.1. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 266,309 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them